Skip to content
Clinical Trials – home

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone

Verifiedinfo

Italy Via Del Vespro 129, 90127 Palermo, Italy

  • 81 trials recruiting
  • Obesity · Primary biliary cholangitis · Arteriosclerosis
  • Adults and children

About Specializations

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone in Palermo, Italy specialises in clinical trials of conditions such as Obesity, Primary biliary cholangitis, Arteriosclerosis, Metabolic dysfunction-associated steatohepatitis, and other specialisations. This site conducts important research.

Main research areas of the site

Ophthalmology and Eye Diseases

At Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, clinical research in Eye Diseases focuses on common and vision-threatening conditions, with studies aimed at improving treatment outcomes and post-surgical recovery.

  • Neovascular Age-Related Macular Degeneration
  • Thyroid Eye Disease
  • Postoperative inflammation after cataract surgery

This area includes trials testing new therapies and evaluating how to better control inflammation and preserve visual function.

Oncology and Hematologic Malignancies

A major part of the site’s research portfolio covers Neoplasms and blood cancers, with studies designed to assess new cancer treatments, compare them with standard care, and improve disease control.

  • Breast Cancer
  • Multiple Myeloma
  • Acute Myeloid Leukemia
  • Head and Neck Squamous Cell Carcinoma

These trials explore both targeted and immunotherapy-based approaches, aiming to extend survival and refine treatment strategies for difficult-to-treat cancers.

Cardiovascular and Metabolic Research

The site conducts extensive studies in Cardiovascular Diseases and Metabolic Disorders, reflecting a strong interest in prevention, risk reduction, and long-term disease management.

  • Atherosclerotic Cardiovascular Disease
  • Atrial Fibrillation
  • Hypertension
  • Type 2 Diabetes Mellitus
  • Obesity

Research here often evaluates new therapies for lowering cardiovascular risk, improving blood sugar control, and supporting healthier weight and lipid profiles.

Liver and Digestive System Disorders

A substantial share of trials at this hospital address Digestive System Diseases, especially chronic liver conditions and inflammatory bowel disease, with an emphasis on symptom relief and slowing progression.

  • Primary Biliary Cholangitis
  • Non-Alcoholic Steatohepatitis
  • Chronic Hepatitis B
  • Ulcerative Colitis
  • Crohn's disease

The research includes studies of new treatments for liver inflammation, fibrosis, cholestatic symptoms, and bowel inflammation.

Neurology, Immunology, and Autoimmune Disease

Clinical trials in Nervous System Diseases and Immune System Diseases investigate conditions that affect movement, memory, and immune regulation, with a focus on symptom control and disease slowing.

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Multiple Sclerosis
  • Generalized Myasthenia Gravis
  • Sjögren’s Syndrome

The studies aim to test new therapies, improve patient-reported outcomes, and better understand autoimmune and neurodegenerative disease activity.

Respiratory, Infectious, and Inflammatory Conditions

Research at the site also spans Respiratory Tract Diseases, Virus Diseases, and inflammatory disorders, supporting efforts to improve infection control and long-term symptom management.

  • Asthma
  • Bronchiectasis
  • Pneumonia
  • Respiratory Syncytial Virus Infections
  • HIV Infections

These trials are designed to evaluate treatment effectiveness, reduce exacerbations, and strengthen care for patients with chronic or recurrent respiratory and infectious diseases.

Rare Diseases, Genetic Disorders, and Other Specialized Studies

The portfolio at Policlinico Paolo Giaccone also includes specialized research in rare and complex conditions, combining Analytical, Diagnostic and Therapeutic Techniques with targeted disease-specific studies.

  • Primary Myelofibrosis
  • Familial Hypercholesterolemia
  • Congenital Adrenal Hyperplasia
  • Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
  • Neuroendocrine tumors

This work supports earlier diagnosis, better risk assessment, and the development of more precise therapies for uncommon and hard-to-treat diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Via Del Vespro 12990127 PalermoItaly
Recruiting now
81 trials
Conditions studied
128
Partner status
Verified

More sites in PalermoItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

192 clinical trials

Dyslipidaemia

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dextromethorphan Hydrobromide
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Bronchiectasis

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.